Celgene Corporation (CELG)
Trading Center
Loading...
Symbols:
CELG Forum Topics
- All Comments on CELG
- General Discussion on CELG
- Investing in Stem Cell Stocks: Growth Industry of the Future? [view article]
- Latin Lovers - Fast Money Recap (8/21/08) [view article]
- Poniard Pharmaceuticals: Platinum Rediscovered (Part II) [view article]
- In Tech We Trust - Fast Money Recap (6/20/08) [view article]
- Huge Opportunity - Fast Money Midday (8/14/08) [view article]
- Cancer Stocks on the Go: Winners and Losers [view article]
- Oncology Conference Countdown: What Will Pharma and Biotech Companies Report? [view article]
- S&P 500's Best and Worst Net Income Change [view article]
- When Greenspan Talks - Fast Money Recap (7/31/08) [view article]
- Don't Sell Celgene - Cramer's Lightning Round (7/30/08) [view article]
- Bargain Hunting: Stocks With Strong Earnings Growth [view article]
- Positive on Pop - Cramer's Lightning Round (7/31/08) [view article]
loading ...Recent CELG Articles
- Latin Lovers - Fast Money Recap (8/21/08)
- Huge Opportunity - Fast Money Midday (8/14/08)
- My Model Biotech Picks: What's Hot and What's Not
- The Long Case for Celgene Corp.
- KV Pharmaceutical's Motion for Rule 11 Sanctions in Ritalin LA Case Denied
- S&P 500's Best and Worst Net Income Change
- When Greenspan Talks - Fast Money Recap (7/31/08)
- Time for Biotech? - Fast Money Recap (07/29/08)
- Biotech Bucks the Market Trend
- A Biotech Bloom in July
- Full List of Articles »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
It
Bargain Hunting: Stocks With Strong Earnings Growth [view article]
Ames, what do you know about TIE. Why do you like it? Boon Pickens ones less than 1% of the stock.Reply
Tiedeman
Take a Load Off Fannie - Fast Money Recap (7/10/08) [view article]
The US housing sector will remain depressed for the next 10 years, not the next 10 months. ReplyTiedeman
GM an Unlikely Hero - Fast Money Recap (7/1/08) [view article]
All of this crap is going lower. ReplyTake a Load Off Fannie - Fast Money Recap (7/10/08) [view article]
Fanny and Freddy with 200 over compensated bureaucrats as "over_sight" watch dogs ran up 10 trillion eigh hundred billion in debt for the dumb people in this country to pay off. Why do we think our government can solve our problems when their own house is in shambles? Anybody with a brain has seen this coming. ReplyTiedeman
Bargain Hunting: Stocks With Strong Earnings Growth [view article]
TIE has been decimated. She will rise again. Boone Pickens owns this name ReplyCelgene Corp. Q1 2008 Earnings Call Transcript [view article]
Some statements follow from a layperson from both a clinical and financial paradigm, who has a fascination with biopharmaceuticals, so what is said is only what I believe or understand:Celgene may be one of the top ten biopharmaceutical companies in existence out of 200 companies or so, and one of the few that are actually profitable.
Thalmide is the comeback drug of all drugs considering its history, yet proved itself to be an asset in the onconology. More importantly, Revlimid was approved a couple of years ago and is a cleaner drug than thalmide. Revlimid is a immunomodulating drug that has many mechanisms of action that delay the progression of multiple myeloma and in some cases, remission occurs when patients take this medication. A deadly hematological cancer, about one third of all cases can advance to leukemia from multiple myeloma. Revliid stops the spread of myeloma for several months, and is highly active against the many etiologies and aspects of this disease state, along with being highly efficacious and safe for use, and this has been proven often. Revlinid increases the survival and response rates to ensure durable disease control for appropriate patients. Doctors adapted and contine to adopt to Revlinid rather quickly because of the clinical data behind the drug that has continuously proven it to be very safe and efficacious compared with previous treatment options available. For anemia, most patients on Revlimid achieve independence from transfusions during treatment with this medication. Not bad or being an analogue of Thalmide.
Pts. on Revlimid has improved complete response rates due to the drug being a powerful angiogenesis inhibitor and catalyst of apoptosis in regards to tumor destruction. More incredibly compelling traits of this drug is that it inhibits TNF and continued cancer cell growth, while simulating the production of T-cells, interleukin, and interferon, as well as being an excellent cytogenic remitting agent as well, all of which benefit a patient who has a cancer of this nature.
Revlimid is approaching 2 billion annual sales due to the preferred agent for the diseases for which it treats, with Velcade being the only competitor, and not much of one at that. Celgene's pipeline is interesting as well.
Celgene is one of the most richly valued biopharmaceutical companies relative to it's earnings. The company remains independent, and finally, Celgene puts 2 to 3 times as much revenue in thie research and development than other drug makers, which is 30 to 40 percent of thier annual revenue. Thier innovation is obvious, and acquisitions appropriate. I'm sure haematolgists would concur with much of what has been written. Pt's actually get thier money's worth with this agent. Reply
Commodities Cool Off - Fast Money Recap (7/7/08) [view article]
Great article on oil trusts today on greenfaucet. Talk about how its the perfect way to protect yourself from inflation, how the government created this economic mess, and why old sands will do well long term- hedging. check it out.www.greenfaucet.com/th...
there's a part II coming as well-- discussion about the risks of oil sands and taxes. Reply
ng
Bargain Hunting: Stocks With Strong Earnings Growth [view article]
Concentrate on big cap multinational consumer goods companies ReplyBargain Hunting: Stocks With Strong Earnings Growth [view article]
delete those oil related companies and put ITWO in. ReplyBargain Hunting: Stocks With Strong Earnings Growth [view article]
If you're going to look at, for example, the gain of these stocks over the last year, then you need to know what the 5-year-growth estimates were for them a year ago, not what it is today. They may have gone up in the past year because the estimates have gone up (Massey Energy comes to mind), in which case it's not surprising that those with high estimates also have high growth in the past year. ReplyBargain Hunting: Stocks With Strong Earnings Growth [view article]
My point is that the investing strategy betting on high growing stocks is successful. ReplyBargain Hunting: Stocks With Strong Earnings Growth [view article]
Do you have a Opinion or a View ? ReplyGM on the Skids - Fast Money Recap (7/2/08) [view article]
so merrillynch thinks gm may go bankrupt. that is enough to make me at least put them on a watch list with ford as a potential long term comeback. oh mer is further down the list along with citi and the other major financials. probably a very longterm watch. the financials will go much lower before i will even consider them. ReplyGM on the Skids - Fast Money Recap (7/2/08) [view article]
The fast money TV show is around for one reason to make money from advertising. ReplyGM on the Skids - Fast Money Recap (7/2/08) [view article]
In the global markets, is there ANYTHING that is not impossible, seeing that that exciting really is a double or tripple negative! Reply